LEXX · CIK 0001348362 · operating
Lexaria Bioscience Corp. (LEXX) is a pharmaceutical preparations company incorporated in NV, listed on the Nasdaq. With a market capitalization of $17 million, Lexaria Bioscience Corp. is a micro-cap company. The stock currently trades at $0.69, down 2.82% today, with a 52-week range of $0.46–$1.90.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $-0.66 | — | -40.4% | |
| 2024 | $-0.47 | — | — | |
| 2023 | — | — | — | |
| 2022 | — | — | — | |
| 2021 | — | — | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — | |
| 2018 | — | — | — | |
| 2017 | — | — | — | |
| 2016 | — | — | — | |
| 2015 | — | — | — | |
| 2013 | — | — | — | |
| 2012 | — | — | — | |
| 2011 | $-0.04 | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2025-08-31 | 2025-11-28 | 0001640334-25-002225 | SEC ↗ |
| 2024-08-31 | 2024-11-26 | 0001640334-24-001787 | SEC ↗ |
| 2023-08-31 | 2023-11-20 | 0001640334-23-002227 | SEC ↗ |
| 2022-08-31 | 2022-11-28 | 0001640334-22-002512 | SEC ↗ |
| 2021-08-31 | 2021-11-29 | 0001640334-21-002981 | SEC ↗ |
| 2020-08-31 | 2020-10-15 | 0001640334-20-002561 | SEC ↗ |
| 2019-08-31 | 2019-11-14 | 0001640334-19-002303 | SEC ↗ |
| 2018-08-31 | 2018-11-14 | 0001640334-18-002165 | SEC ↗ |
| 2017-08-31 | 2017-11-27 | 0001062993-17-005078 | SEC ↗ |
| 2016-08-31 | 2016-11-29 | 0001062993-16-012493 | SEC ↗ |
| 2015-08-31 | 2015-11-27 | 0001062993-15-006451 | SEC ↗ |
| 2013-10-31 | 2014-01-24 | 0001062993-14-000329 | SEC ↗ |
| 2012-10-31 | 2013-01-29 | 0001062993-13-000426 | SEC ↗ |
| 2011-10-31 | 2012-01-30 | 0001062993-12-000301 | SEC ↗ |
| 2010-10-31 | 2011-01-31 | 0001204459-11-000244 | SEC ↗ |
| 2009-10-31 | 2010-01-20 | 0001137171-10-000034 | SEC ↗ |